PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ingestion of fava bean protein (0.33 g/kg) immediately after resistance exercise did not evoke an increase in resting myofibrillar fractional synthetic rate compared to a negative control [PMID:36145064].
A cream containing 20% broad bean extract (seeds and pods) resulted in a decrease in the thickness of axillary hairs in female volunteers [PMID:38966632].
L-dopa, isolated from Vicia faba seeds, is used in the management of Parkinson's disease [PMID:35342258].
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 30372002 (2006) — Pathophysiology of favism. · Folia haematologica (Leipzig, Germany : 1928)
- 2.PMID: 39123563 (2024) — Impact of Fava Bean (Vicia faba) Processing on Quality Characteristics and Digestibility of a Protein-Rich Snack. · Foods (Basel, Switzerland)
- 3.PMID: 38225150 (2024) — Fava bean (Vicia faba L.) protein concentrate added to beef burgers improves the bioaccessibility of some free essential amino acids after in vitro oral and gastrointestinal digestion. · Food research international (Ottawa, Ont.)
- 4.PMID: 34427764 (2021) — Tissue culture-based genetic improvement of fava bean (Vicia faba L.): analysis on previous achievements and future perspectives. · Applied microbiology and biotechnology
- 5.PMID: 33648264